Introduction. Dioctyl terephthalate (DOTP) is an ester of 2-ethylhexanol and terephthalic acid. It is a new generation plasticizer that is used as a more environmentally friendly and safer substitute for dioctyl phthalate (DOP) and other phthalates. Despite the established low level of toxic effects on the human body, the expansion of industrial production of DOTP requires an in-depth assessment of its safety. Material and methods. The effect of DOTP on the motility of isolated segments of the small intestine of rats was assessed under chronic inhalation exposure for 120 days at concentrations of 3.4 and 18.6 mg/m3. Results. The course exposure to dioctyl terephthalate, regardless of the dose, reduces the spontaneous contractile activity and adrenoreactivity of the smooth muscle cells of the rat small intestine, and also increases their sensitivity to cholinergic effects. Limitations. The study demonstrates a change in the spontaneous contractile activity isolated segments rat small intestine under the influence of the main mediators autonomic nervous system. Additional research is required for a detailed assessment possible mechanisms for the development of the identified changes. Conclusion. As a result of the study, it was found that chronic inhalation of dioctyl terephthalate at concentrations of 3.4 and 18.6 mg/m3 equally cause a decrease in the tone and amplitude of contractions in isolated segments of the rat small intestine. Chronic exposure to DOTP leads to a change in the reactivity of small intestine myocytes to mediators of the autonomic nervous system. The results obtained indicate that DOTP, when administered by inhalation, is enterotropic.
Introduction. Despite the large-scale use of asymmetric dimethylhydrazine (UDMH) in the domestic rocket and space industry, its biomarkers of exposure in blood plasma and urine, as well as biomarkers of cardiotoxic effects, have not yet been described. Material and methods. The study of blood and urine samples of rats after a single injection of 10 mg/kg UDMH (1/16 LD50) was carried out by HPLC-MS. The determination of the non-metabolized form of UDMH was also carried out using the method of gas chromatography with mass-selective detection with preliminary derivatization with 4-pyridinecarboxyaldehyde. The cardiotoxic effect of UDMH was assessed on a model of an isolated rat heart with subchronic intragastric administration for 28 days at doses of 0,02; 0,2; 2,0 mg/kg. Results. It has been established that the main metabolites of UDMH are dimethylhydrazones of pyridoxal (vitamin B6) and pyruvic acid (pyruvate). The possibility of determining the non-metabolized form of UDMH in blood and urine by HPLC-MS was shown, concentrations reach 10-60 ng/ml of blood plasma and 200-2000 ng/ml. The use of UDMH leads to an increase in the mass coefficient of the heart at a dose of 2,0 mg/kg. In ex vivo experiments on the rat heart, the cardiotoxic effect of UDMH was shown at subchronic use at a dose of 0,2 mg/kg and above, expressed in significant dilatation of the coronary bloodstream and left ventricle, the development of pronounced negative inotropic and chronotropic effects, and a decrease in the maximum rate of contraction and relaxation of the left ventricle. ventricle, reflecting the inhibition of myocardial energy metabolism. Limitations of the study. In the work, biomarkers were detected after a single intragastric injection of NDMG, the toxicokinetic characteristics of biomarkers and their retrospectivity were not evaluated. Conclusion. The main metabolites of UDMH with intravenous administration of 1/16 DL50 are dimethylhydrazones of pyridoxal (vitamin B6) and pyruvic acid (pyruvate). With subchronic administration, UDMH has cardiotoxicity at a dose of 0,02 mg/kg and above.
Introduction. A comprehensive approach to treatment of chronic prostatitis, representing a widespread and poorly treatable disease, includes the use of antibacterial, anti-inflammatory medicines, etc. In this context, a promising approach to the treatment of chronic prostatitis involves the use of bioregulatory peptides isolated from bovine prostate tissue.Objective. To study the effect of cattle prostate extract containing bioregulatory peptides on the functional activity of lymphatic vessels.Маterials and methods. The study was performed on isolated lymphatic vessels of rats. The range of studied concentrations of the substance was 2–10 µg/ mL (in terms of water-soluble peptides).Results. Bioregulatory peptides included into the prostate extract impacts the vasomotor activity of lymphatic vessels. In the range of studied concentrations (2–10 µg/ml), the substance has a stimulating effect on lymphangion motility. This is realized by increasing the rate of lymphatic vessel contractions, which effect is most pronounced at the concentration of 5 µg/ml as a 37.6% (p ≤ 0.05) of base level. The obtained stimulating effect is stable during 30-min “washing” of lymphatic vessels with physiological solution.Conclusions. Water-soluble bioregulatory peptides contained in the extract of cattle prostate and having organotropic action on the prostate gland may contribute to the reduction of tissue edema by activating the motility of pelvic lymphatic vessels.
Using ex vivo technologies to detect early signs of functional disorders caused by the action of industrial and household xenobiotics | Laptev | Toxicological Review Использование технологий ex vivo для выявления ранних признаков функциональных нарушений, вызванных действием промышленных и бытовых ксенобиотиков | Лаптев | Токсикологический вестник